The Vascular Endothelial Growth Factor (VEGF) test measures the amount of VEGF in your blood.
VEGF is a protein that stimulates the growth of new blood vessels — a process known as angiogenesis. It’s produced by your body when tissues aren’t getting enough oxygen, helping restore blood flow and oxygen supply to those areas.
Why VEGF Matters
VEGF plays a vital role in normal body functions, including:
-
Supporting blood vessel formation after injury or exercise
-
Aiding bone formation and the creation of new blood cells
-
Maintaining healthy circulation in organs like the lungs and brain
However, too much VEGF can contribute to disease processes, particularly cancer and vascular conditions.
VEGF and Cancer
Many tumors rely on VEGF to grow. As cancer cells multiply, they release VEGF to build new blood vessels that feed them oxygen and nutrients.
High VEGF levels are often linked to faster tumor growth, metastasis (spread to other areas), and sometimes a poorer prognosis.
Because of this, several cancer therapies are designed to block VEGF activity, effectively starving tumors of their blood supply. Measuring VEGF levels can help doctors monitor how well these treatments are working.
VEGF and Other Health Conditions
VEGF doesn’t just promote vessel growth—it can also make blood vessels leakier. This can cause fluid buildup and swelling in tissues.
Examples include:
-
Brain cancers, where VEGF-induced swelling can raise intracranial pressure
-
Eye diseases such as diabetic retinopathy and age-related macular degeneration, where VEGF-driven vessel leakage can damage vision
VEGF has also been studied in neurodegenerative disorders (like Alzheimer’s and ALS), where abnormal VEGF signaling may contribute to nerve cell damage.
VEGF and POEMS Syndrome
The VEGF test is especially valuable for diagnosing and monitoring POEMS syndrome, a rare condition marked by:
-
Polyneuropathy (nerve damage)
-
Organomegaly (enlarged organs)
-
Endocrinopathy (hormonal problems)
-
Monoclonal gammopathy (abnormal antibody production)
-
Skin changes
VEGF levels are typically very elevated in POEMS syndrome, helping distinguish it from other causes of neuropathy or plasma cell disorders.
Normal VEGF levels, however, do not rule out POEMS syndrome.
Key Insights
-
Low oxygen (hypoxia) stimulates VEGF production to restore tissue oxygenation.
-
High VEGF levels may indicate tumor activity, inflammation, or POEMS syndrome.
-
Low VEGF levels have been associated with some neurological and psychiatric conditions, including depression and Alzheimer’s disease.
Summary
The VEGF test helps assess how your body regulates blood vessel growth and oxygen supply.
It’s mainly used to:
-
Evaluate or confirm POEMS syndrome
-
Monitor cancer treatment response
-
Investigate unexplained vascular or neurological symptoms
References
Melincovici CS, Bosca AB, Susman S, Marginean M, Mihu C, Istrate M, Moldovan IM, Roman AL, Mihu CM. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455-467. PMID: 30173249.
Storkebaum E, Carmeliet P. VEGF: a critical player in neurodegeneration. J Clin Invest. 2004 Jan;113(1):14-8. doi: 10.1172/JCI20682. PMID: 14702101; PMCID: PMC300888.
Mateo I, Llorca J, Infante J, Rodríguez-Rodríguez E, Fernández-Viadero C, Peña N, Berciano J, Combarros O. Low serum VEGF levels are associated with Alzheimer's disease. Acta Neurol Scand. 2007 Jul;116(1):56-8. doi: 10.1111/j.1600-0404.2006.00775.x. PMID: 17587256.
Isung, J., Aeinehband, S., Mobarrez, F. et al. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl Psychiatry 2, e196 (2012). https://doi.org/10.1038/tp.2012.123
Isung J, Mobarrez F, Nordström P, Asberg M, Jokinen J. Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide. World J Biol Psychiatry. 2012 Sep;13(6):468-73. doi: 10.3109/15622975.2011.624549. Epub 2011 Nov 18. PMID: 22098148.
Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003 Aug;34(4):383-94. doi: 10.1038/ng1211. PMID: 12847526.
Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996 Apr 4;380(6573):435-9. doi: 10.1038/380435a0. PMID: 8602241.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.